EU HTA Regulation Adoption Now A Formality Despite Medtech Industry Concerns
Executive Summary
The EU is on the cusp of a new era for HTA with a new regulation and new structures falling into place. The medtech industry’s concerns have not been addressed, but it hopes for changes ahead.
You may also be interested in...
EU HTA Regulation: ‘Another Layer Of Bureaucracy For Medtech To Overcome’
MedTech Europe is “highly skeptical” about the added value of the forthcoming EU Regulation on Health Technology Assessment for health systems and citizens and explained to Medtech Insight how it currently fails medtech.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.